A step forward in antibiotic use and resistance monitoring: a quarterly surveillance system pilot in 11 European Union/European Economic Area countries, September 2017 to May 2020

  21 November 2022

In the European Union/ European Economic Area, surveillance data on antimicrobial resistance (AMR) and antimicrobial use (AMU) are collected on an annual basis. We wanted to address the feasibility of developing a quarterly surveillance system for AMU and AMR in both hospitals and primary care.

We identified that 13 of the 17 partners in the pilot project could submit data within 6 months. However, in order to increase the frequency at which AMU and AMR data are provided, committed institutional support, dedicated human resources, and coordination of microbiological and antimicrobial use data sources – which implies common indicators and modern integrated IT systems – are needed.

More frequent AMU and AMR surveillance reporting appears feasible in the EU/EEA to timely inform interventions at local, regional and national levels. However, there are some caveats that should be addressed before quarterly surveillance can be implemented at the European level.

Further reading: EuroSurveillance
Author(s): Germán Peñalva et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Ambassador Network

Join the AMR Insights Ambassador Network today!

Connect to over 650 AMR professionals and students in 65 countries!

Register

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed